Betsy Smith

671 total citations
11 papers, 218 citations indexed

About

Betsy Smith is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Betsy Smith has authored 11 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Betsy Smith's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and HIV/AIDS Research and Interventions (4 papers). Betsy Smith is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and HIV/AIDS Research and Interventions (4 papers). Betsy Smith collaborates with scholars based in United States, Netherlands and South Africa. Betsy Smith's co-authors include Lynne Mofenson, George McSherry, Edmund V. Capparelli, Mark Mirochnick, John L. Sullivan, Hulin Wu, Wayne M. Dankner, Katherine Luzuriaga, Sandra Burchett and Gregory Ciupak and has published in prestigious journals such as NeuroImage, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Betsy Smith

11 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Betsy Smith United States 7 173 101 68 42 39 11 218
Francis Atéba Ndongo Cameroon 8 155 0.9× 82 0.8× 53 0.8× 31 0.7× 48 1.2× 26 217
Coca Necsoi Belgium 8 97 0.6× 77 0.8× 40 0.6× 10 0.2× 53 1.4× 23 146
Chiara Montrucchio Italy 9 126 0.7× 63 0.6× 83 1.2× 15 0.4× 41 1.1× 14 211
Raffaella Bucciardini Italy 11 263 1.5× 171 1.7× 87 1.3× 7 0.2× 98 2.5× 27 318
Corine Chazallon France 6 284 1.6× 214 2.1× 53 0.8× 51 1.2× 79 2.0× 12 320
Choy Man United Kingdom 7 162 0.9× 88 0.9× 226 3.3× 10 0.2× 49 1.3× 12 346
Rodica Van Solingen‐Ristea United States 11 296 1.7× 187 1.9× 119 1.8× 34 0.8× 38 1.0× 31 375
Amina Carlebach Germany 11 346 2.0× 255 2.5× 132 1.9× 20 0.5× 66 1.7× 15 432
Richard Court South Africa 11 275 1.6× 113 1.1× 116 1.7× 40 1.0× 11 0.3× 26 333
Claire M. Naftalin Singapore 9 178 1.0× 44 0.4× 89 1.3× 7 0.2× 51 1.3× 15 220

Countries citing papers authored by Betsy Smith

Since Specialization
Citations

This map shows the geographic impact of Betsy Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betsy Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betsy Smith more than expected).

Fields of papers citing papers by Betsy Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betsy Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betsy Smith. The network helps show where Betsy Smith may publish in the future.

Co-authorship network of co-authors of Betsy Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Betsy Smith. A scholar is included among the top collaborators of Betsy Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betsy Smith. Betsy Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Clarke, Diana F., Edward P. Acosta, Jiajia Wang, et al.. (2020). Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1–Exposed Neonates at Risk of Infection (IMPAACT P1110). JAIDS Journal of Acquired Immune Deficiency Syndromes. 84(1). 70–77. 13 indexed citations
2.
Clarke, Diana F., Mark Mirochnick, Edward P. Acosta, et al.. (2019). Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(4). 392–398. 5 indexed citations
3.
Svensson, Elin M., Jeannine du Bois, Veronique de Jager, et al.. (2018). Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children. British Journal of Clinical Pharmacology. 84(10). 2384–2392. 24 indexed citations
4.
Swindells, Susan, Amita Gupta, Michael D. Hughes, et al.. (2018). Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003). The International Journal of Tuberculosis and Lung Disease. 22(9). 1016–1022. 1 indexed citations
5.
Pinto, Jorge, Edmund V. Capparelli, Meredith G. Warshaw, et al.. (2017). A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines. The Pediatric Infectious Disease Journal. 37(2). e29–e35. 6 indexed citations
6.
Rizk, Matthew L., Lihong Du, Larissa Wenning, et al.. (2015). Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV‐infected children 4 weeks to 18 years of age. The Journal of Clinical Pharmacology. 55(7). 748–756. 13 indexed citations
7.
Chandwani, Sulachni, Judy A. Beeler, Hong Li, et al.. (2011). Safety and Immunogenicity of Early Measles Vaccination in Children Born to HIV-Infected Mothers in the United States: Results of Pediatric AIDS Clinical Trials Group (PACTG) Protocol 225. The Journal of Infectious Diseases. 204(suppl_1). S179–S189. 17 indexed citations
8.
Zorrilla, Carmen, Russell Van Dyke, Arlene Bardeguez, et al.. (2007). Clinical Response and Tolerability to and Safety of Saquinavir with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Mothers and Their Infants. Antimicrobial Agents and Chemotherapy. 51(6). 2208–2210. 13 indexed citations
9.
Smith, Donald F., K. Marthi, Steen Jakobsen, et al.. (2006). PET neuroimaging of racemic [11C]mirtazapine and enantiomers: Pharmacokinetic models and alpha-noradrenergic binding sites. NeuroImage. 31. T125–T125. 1 indexed citations
10.
Capparelli, Edmund V., Mark Mirochnick, Wayne M. Dankner, et al.. (2003). Pharmacokinetics and tolerance of zidovudine in preterm infants. The Journal of Pediatrics. 142(1). 47–52. 62 indexed citations
11.
Luzuriaga, Katherine, Hulin Wu, Margaret McManus, et al.. (1999). Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants. Journal of Virology. 73(1). 362–367. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Atéba Ndongo Breakdown of academic impact, for papers by Coca Necsoi Breakdown of academic impact, for papers by Chiara Montrucchio Breakdown of academic impact, for papers by Raffaella Bucciardini Breakdown of academic impact, for papers by Corine Chazallon Breakdown of academic impact, for papers by Choy Man Breakdown of academic impact, for papers by Rodica Van Solingen‐Ristea Breakdown of academic impact, for papers by Amina Carlebach Breakdown of academic impact, for papers by Richard Court Breakdown of academic impact, for papers by Claire M. Naftalin
Rankless by CCL
2026